Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma

Cancer

Volumn 88, Issue 2, 2000, Pages 381-388

  Cantuaria, Guilherme ^a,d   Magalhaes, Albino ^b   Angioli, Roberto ^a   Mendez, Luis ^a   Mirhashemi, Ramin ^a   Wang, Jianqiang ^c   Wang, Peng ^c   Penalver, Manuel ^a   Averette, Hervy ^a   Braunschweiger, Paul ^d  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoma; Glut 1; Nitric oxide; Ovary; S nitroso N acetyl peniciliamine

Indexed keywords

CISPLATIN; NITRIC OXIDE DONOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MONOSACCHARIDE TRANSPORT PROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; OVARIAN NEOPLASMS; PENICILLAMINE; S-NITROSO-N-ACETYLPENICILLAMINE; TUMOR CELLS, CULTURED;

EID: 0034650461     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000115)88:2<381::AID-CNCR20>3.0.CO;2-M     Document Type: Article

References (54)

1. Ignaro LJ, Byrns RE, Buga GM, Wood KS. Endothelium derived relaxation factor from pulmonary artery and vein possess pharmacologic and chemical properties identical to those of nitric oxide. Circ Res 1987;61:866-79.
2. Nguyen BL, Saitoh M, Ware JA. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 1991;261:H1043-52.
3. Salvemini D, Currie MG, Mollace V. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clin Invest 1996;97:2562-68.
4. Dawson VL, Dawson TM. Physiological and toxilogical actions of nitric oxide in the central nervous system. In: Ignaro L, Murad F, editors. Advances in pharmacology nitric oxide: biochemistry, molecular biology and therapeutics, vol 34. New York: Academic Press, 1995:323-42.
5. Hibbs JB, Taintor RR, Varvin Z. Macrophage cytotoxicity: role of L-arginine deaminase and amino nitrogen oxydation to nitrite. Science 1987;235:473-6.
6. Crow JP, Beckman JS. The role of peroxynitrite in nitric oxide-mediated toxicity [review]. Curr Topics Microbiol Immunol 1995;196:57-73.
7. Beckman JS, Beckman TW, Chen J, Marshall PA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:620-4.
8. Braunschweiger PG, Cameron D, Sharpe L, Ali-Osman F, Grimm E, Buzaid, A. Cisplatin and nitric oxide have synergistic antitumor activity in cP resistant human melanoma cells. Proc AACR 1996;37:1865.
9. Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, et al. Molecular biology of mammalian glucose transporters [review]. Diabetes Care 1990;13:198-208.
10. Gould GW, Bell GI. Facilitative glucose transporters: an expanding family [review]. Trends Biochem Sci 1990;15:18-23.
11. Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, et al. Overexpression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990;170:223-30.
12. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 1993;72:2979-85.
13. Nishioka T, Oda Y, Seino Y, Yamamoto T, Inagaki N, Yano H, et al. Distribution of the glucose transporters in human brain tumors. Cancer Res 1992;52:3972-9.
14. Mellanen P, Minn H, Grenman R, Harkonen P. Expression of glucose transporters in head and neck tumors. Int J Cancer 1994;56:622-9.
15. Louie K, Behens BC, Kinsella TJ, Hamilton TC, Grotzinger KR, McKoy WM, et al. Radiation survival parameters of antineoplastic drug sensitive and resistant human ovarian cancer cell lines and their modification by buthione sulfoximine. Cancer Res 1985;45:2110-5.
16. Ramirez J, Yu LB, Li J, Braunschweiger PG, Wang, PG. Glyco-S-nitrosothiols, a novel class of NO donor compounds. Bioorg Med Chem Lett 1996;6:2575-80.
17. Braunschweiger PG, Basrur VS, Santos O, Perras JP, Markoe AM, Houdek P, et al. In vitro modulation of cisplatin tumor cell cytotoxicity by interleukin-1α and resident tumor host cells. Biotherapy 1997;10:129-37.
18. Chou TC, Talalay P. Applications of the median effect principle for the assessment of low dose risk of carcinogens and for the quantitation of synergism and antagonism of chemotherapeutic agents. In: Harrap KR, Conners TA, editors. New avenues in developmental cancer chemotherapy. New York: Academic Press, 1987:37-63.
19. Chakrabarti R, Jung CY, Lee TP, Liu H, Mookerjee BK. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol 1994;152:2660-8.
20. Hsu SM. Use of avidin biotin-peroxidase complex in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577.
21. Giorno RA. Comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 1984;2:161.
22. Nathan C, Hibbs JB. Role of nitric oxide in macrophage antimicrobial activity. Curr Opin Microbiol 1991;3:65-70.
23. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995;92:7162-6.
24. Mitrovic B, Ignarro LJ, Vinters HV, Akers MA, Schmid I, Uittenbogaart C, et al. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 1995; 65:531-9.
25. Walker MW, Kinter MT, Roberts RJ, Spitz DR. Nitric oxide-induced cytotoxicity: involvement of cellular resistance to oxidative stress and the role of glutathione in protection. Pediatr Res 1995;37:41-9.
26. Warburg O. The metabolism of tumors. New York: Richard Smith 1931:29-169.
27. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter message RNA as induced by ras and src oncogenes. Science 1987;235:1492-5.
28. Pohl J, Bertram B, Hilgard P, Nowrousian MR, Stuben J, Wiessler M. D-19575 - a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport. Cancer Chemother Pharmacol 1995;35:364-70.
29. Maryanoff BE, Costanzo MJ, Nortey SO, Greco MN, Shank RP, Schupsky JJ, et al. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives. J Med Chem 1998;41:1315-43.
30. Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 1994;30:643-52.
31. Braunschweiger PG, Wang PG, Ramirez J, Cameron D, Grimm E, Ali-Osman F, et al. Targeting of nitric oxide to tumor cells. The synthesis and cytotoxicity of gluco-2-[S-nitroso]-N-acetyl penicillamine. Proc AACR 1997;38:217.
32. Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 1997;240:419-24.
33. Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-48.
34. Mohr S, Zech B, Lapetina EG, Brune B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun 1997;238:387-91.
35. Haddad IY, Zhu S, Crow J, Barefield E, Gadilhe T, Matalon S. Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am J Physiol 1996;270:L898-906.
36. Wink DA, Hanbauer I, Grisham MB, Laval F, Nims RW, Laval J, et al. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms [review]. Curr Topics Cell Regul 1996;34:159-87.
37. Wink DA, Osawa Y, Darbyshire JF, Jones CR, Eshenaur SC, Nims RW. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys 1993;300:115-23.
38. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochemical J 1996;314:877-80.
39. Mohr S, Stamler JS, Brune B. Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett 1994;348:223-7.
40. Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage derived NO. J Exp Med 1991;174:761-7.
41. Routledge MN, Wink DA, Keefer LK, Dipple A. DNA sequence changes induced by 2 nitric oxide donor drugs in SupF assay. Chem Res Toxicol 1994;7:628-32.
42. Szabo C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 1996;93:1753-8.
43. Gopalakrishna R, Chen ZH, Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 1993;268:27180-5.
44. Matthews JR, Botting CH, Panico M, Morris HR, Hay RT. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 1996;24:2236-42.
45. Graziewicz M, Wink DA, Laval F. Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage. Carcinogenesis 1996;17:2501-5.
46. Laval F, Wink DA. Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis 1994;15:443-7.
47. Wink DA, Laval J. The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 1994;15:2125-9.
48. Beckman JS. The physiological and pathological chemistry of nitric oxide. In: Lanchester J, editor. Nitric oxide principals and actions. San Diego: Academic Press, 1996: 1-82.
49. Bolanos JP, Almeida A, Fernandez E, Medina JM, Land JM, Clark JB, et al. Potential mechanisms for nitric oxide-mediated impairment of brain mitochondrial energy metabolism [review]. Biochem Soc Trans 1997;25:944-9.
50. Richter C, Gogvadze, V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, et al. Oxidants in mitochondria: from physiology to diseases [review]. Biochim Biophys Acta 1995; 1271:67-74.
51. Brown GC. Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: implications for inflammatory, neurodegenerative and ischaemic pathologies [review]. Mol Cell Biochem 1997;174:189-92.
52. Forsayeth J, Gould MK. Stimulatory and inhibitory effects of hydrogen peroxide, diamide and vitamin K-5 on sugar transport in rat soleus muscle. Biochim Biophys Acta 1983;759: 184-91.
53. Heard KS, Diguette M, Heard AC, Carruthers A. Membrane-bound glyceraldehyde-3-phosphate dehydrogenase and multiphasic erythrocyte sugar transport. Exp Physiol 1998; 83:195-202.
54. Dimmeler S, Lottspeich F, Brune B. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1992;267:16771-4.